![]() | STOCKCHASEWhat the experts are saying! |
| There are 2 registered members and 42 guests viewing the site. | Rss Top Picks Feed | Rss Daily Feed |
|
| VAGUE | 0.840 | Geoff Houlton | A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position. | 2008-03-26 |